Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Implementation of a Multipronged Intervention to Improvement Inpatient Sickle Cell Disease Care

Daniela Anderson, Valerie G. Press, Kenneth S. Cohen, Nabil Abou Baker

Blood (2023) 142 (Supplement 1): 5062.

https://doi.org/10.1182/blood-2023-189612

Published: 2023

Journal Articles

Prospective Multi-Center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas

Kirk Cahill, James Godfrey, Chadi Nabhan, Theodore G. Karrison, Jessica Robertson, Justin Kline, Kenneth S. Cohen, Michael R. Bishop, Walter M. Stadler, Reem Karmali, Parameswaran Venugopal, Seo-Hyun Kim, Aaron P. Rapoport, Sonali M. Smith

Blood (2022) 140 (Supplement 1): 6594–6595.

https://doi.org/10.1182/blood-2022-168444

Published: 2022

Journal Articles

Phase II Study of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas: Final Analysis of NCI 8309

Justin Kline, MD, Aaron P. Rapoport, MD, Adam M. Petrich, MD, Kenneth S. Cohen, MD, Sachdev P. Thomas, MD, Sreenivasa Nattam, MD, Krishna Rao, MD, Bethany Sleckman, MD, Walter Stadler, MD, Theodore Karrison, PhD, Sonali M. Smith, MD

Blood (2016) 128 (22): 4147.

https://doi.org/10.1182/blood.V128.22.4147.4147

Published: 2016

Journal Articles

Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial

Natalie Galanina, MD, Sonali M. Smith, MD, Chuanhong Liao, PhD, Adam M. Petrich, MD, Bernadette Libao, Ron Gartenhaus, MD, Jason R Westin, MD, Kenneth S. Cohen, MD, James Knost, MD, Walter Stadler, MD, Austin Doyle, MD, Theodore Karrison, PhD, Leo I. Gordon, MD, Andrew M Evens, DO, MS

Blood (2015) 126 (23): 3990.

https://doi.org/10.1182/blood.V126.23.3990.3990

Published: 2015

Journal Articles

Circulating CD34 + progenitor cell frequency is associated with clinical and genetic factors

Kenneth S. Cohen, Susan Cheng, Martin G. Larson, L. Adrienne Cupples, Elizabeth L. McCabe, Ying A. Wang, Julius S. Ngwa, Roderick P. Martin, Rachael J. Klein, Basma Hashmi, Yin Ge, Christopher J. O'Donnell, Ramachandran S. Vasan, Stanley Y. Shaw, Thomas J. Wang

Blood (2013) 121 (8): e50–e56.

https://doi.org/10.1182/blood-2012-05-424846

Published: 2013

Includes: Supplemental data

Journal Articles

CD34+ Circulating Progenitor Cell Frequency Is Highly Heritable

Kenneth S. Cohen, MD, Susan Cheng, MD, Martin G. Larson, ScD, L. Adrienne Cupples, PhD, Elizabeth L. McCabe, MS, Ying A. Wang, PhD, Roderick P. Martin, ALB, Rachael J. Klein, MS, Basma Hashmi, BS, Christopher J. O'Donnell, MD, Vasan S. Ramachandran, MD, Stanley Y. Shaw, MD, PhD, Thomas J. Wang, MD

Blood (2010) 116 (21): 4309.

https://doi.org/10.1182/blood.V116.21.4309.4309

Published: 2010

Journal Articles

Alemtuzumab-Containing Allogeneic Hematopoietic Cell Transplant (HCT) for Relapsed Lymphomas: Prognostic Factors and Outcome.

Vaishalee P. Kenkre, MD, Sarah Horowitz, Sonali M. Smith, MD, Andrew Artz, MD, MS, Kenneth S. Cohen, MD, Lucy A Godley, M.D., Ph.D., Justin Kline, M.D., Wendy Stock, MD, Koen van Besien, MD

Blood (2009) 114 (22): 2247.

https://doi.org/10.1182/blood.V114.22.2247.2247

Published: 2009

Journal Articles

Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels

Patrick Au, Laurence M. Daheron, Dan G. Duda, Kenneth S. Cohen, James A. Tyrrell, Ryan M. Lanning, Dai Fukumura, David T. Scadden, Rakesh K. Jain

Blood (2008) 111 (3): 1302–1305.

https://doi.org/10.1182/blood-2007-06-094318

Published: 2008

Includes: Multimedia, Supplemental data

Journal Articles

Evidence for incorporation of bone marrow–derived endothelial cells into perfused blood vessels in tumors

Dan G. Duda, Kenneth S. Cohen, Sergey V. Kozin, Jean Y. Perentes, Dai Fukumura, David T. Scadden, Rakesh K. Jain

Blood (2006) 107 (7): 2774–2776.

https://doi.org/10.1182/blood-2005-08-3210

Published: 2006

Includes: Supplemental data

NARROW

Implementation of a Multipronged Intervention to Improvement Inpatient Sickle Cell Disease Care

Prospective Multi-Center Phase I/II Trial of Lenalidomide and Dose-Adjusted EPOCH-R in MYC-Associated B-Cell Lymphomas

Phase II Study of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas: Final Analysis of NCI 8309

Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial

Circulating CD34 + progenitor cell frequency is associated with clinical and genetic factors

CD34+ Circulating Progenitor Cell Frequency Is Highly Heritable

Alemtuzumab-Containing Allogeneic Hematopoietic Cell Transplant (HCT) for Relapsed Lymphomas: Prognostic Factors and Outcome.

Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels

Evidence for incorporation of bone marrow–derived endothelial cells into perfused blood vessels in tumors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only